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Abstract
Objective: To describe chronic disease management programs active in Switzerland in 2007, using an exploratory survey.
Methods: We searched the internet (Swiss official websites and Swiss web-pages, using Google), a medical electronic database (Med-
line), reference lists of pertinent articles, and contacted key informants. Programs met our operational definition of chronic disease man-
agement if their interventions targeted a chronic disease, included a multidisciplinary team (≥ 2 healthcare professionals), lasted at least 
six months, and had already been implemented and were active in December 2007. We developed an extraction grid and collected data 
pertaining to eight domains (patient population, intervention recipient, intervention content, delivery personnel, method of communica-
tion, intensity and complexity, environment, clinical outcomes).
Results: We identified seven programs fulfilling our operational definition of chronic disease management. Programs targeted patients 
with diabetes, hypertension, heart failure, obesity, psychosis and breast cancer. Interventions were multifaceted; all included education 
and half considered planned follow-ups. The recipients of the interventions were patients, and healthcare professionals involved were 
physicians, nurses, social workers, psychologists and case managers of various backgrounds.
Conclusions: In Switzerland, a country with universal healthcare insurance coverage and little incentive to develop new healthcare strate-
gies, chronic disease management programs are scarce. For future developments, appropriate evaluations of existing programs, involve-
ment of all healthcare stakeholders, strong leadership and political will are, at least, desirable.
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Introduction
Even though chronic diseases are the leading causes 
of morbidity, mortality and disability, they are “surpris-
ingly neglected elements of the global-health agenda” 
[1, p. 2152]. Worldwide, they are responsible for 49% 
of the burden of disease and 60% of deaths [2]. In high 
income countries, they represent the 10 first causes 
of  disability-adjusted  life  years  (DALY)  and  are  pro-
jected to be the leading causes of deaths in 2030 [3]. 
The  World  Health  Organization  estimates  that  long-
term conditions now account for most of the disease 
burden in Europe and the US [4]. After the age of 65, 
around  70%  of  the  individuals  present  one  chronic   
disease or more [5]. Because longevity is increasing   
and  populations  age,  the  proportion  of  individuals 
who live with at least one chronic condition is likely to 
increase [6, 7]. Additionally, costs of chronic diseases 
place a large burden on the healthcare system [8, 9], 
and they increase as disability rises [10].
In  Switzerland,  approximately  2/3  of  the  individuals 
aged 65 years and over presents at least one chronic 
condition [11], and figures similar to the international 
burden  of  chronic  diseases  are  found  [12].  Chronic 
disease management (CDM) programs are multifac-
eted interventions aimed at improving quality of care This article is published in a peer reviewed section of the International Journal of Integrated Care   2
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in  patients  presenting  with  such  diseases.  Thus,  if   
effective,  CDM  could  be  very  useful  for  the  Swiss 
healthcare system. However, little is known about the 
supply of CDM in Switzerland.
According to the Disease Management Association of 
America (DMAA), “disease management is a system   
of coordinated health care interventions and communi-
cations for populations with conditions in which patient 
self-care  efforts  are  significant”  [13,  webpage].  At 
best, chronic disease management programs should 
include processes of population identification, the use 
of evidence-based guidelines, multidisciplinary teams, 
patient  self-management  education,  evaluation,  pro-
cess and outcomes measurement, as well as routine 
reporting and feedback [13]. Several uses and defini-
tions of chronic disease management exist [13–18], 
and there is no consensus on its definition. Neverthe-
less, the most recent definitions integrate and describe 
the  individual  components  of  CDM  more  explicitly   
[19]. In fact, chronic disease management programs 
present varying components, duration of interventions, 
and study populations. Therefore, the comparison of 
programs is not easy.
The  most  commonly  targeted  chronic  diseases  are   
diabetes, heart failure, ischemic heart disease, asthma, 
chronic  obstructive  pulmonary  disease  (COPD),  and 
depression. Systematic reviews assessing the effective-
ness of CDM programs have shown that they may be 
effective. For example, CDM programs decreased the 
risk of hospitalization and mortality in patients with heart 
failure [20–22], improved glycemic control and screen-
ing rates in diabetics [23, 24], improved the walking dis-
tance, quality of life and rate of hospitalization of COPD 
patients [25, 26], decreased the severity of symptoms, 
and improved treatment compliance as well as satisfac-
tion among patients with depression [27, 28].
Developed in the United States in the 1990s, chronic 
disease  management  programs  have  more  recently 
been implemented in several European countries and 
used  as  a  system  response  to  problems  that  most 
healthcare systems are facing: organizational, medi-
cal  and  economical  problems [29,  30].  In  Germany, 
for example, CDM has been introduced nationally as 
part of a modification of the Health Law. Indeed, since 
January 2003, CDM programs for five chronic condi-
tions (diabetes, asthma, chronic obstructive pulmonary 
disease, breast cancer and coronary heart diseases) 
have been part of the new risk structure compensation 
scheme of the German statutory health insurance, and 
started to be implemented nationwide [31, 32]. In this 
setting, programs are structured and regulated, and 
need to include a minimum of elements [33].
Switzerland is a small European country of 7.4 million 
inhabitants, spread over three main language regions 
(German,  French,  and  Italian).  It  is  a  federal  state   
composed  of  26  cantons.  While  the  federal  health 
responsibilities  relate  to  legislative  and  supervisory 
roles, the cantons are responsible for the provision, 
organization and financing of health services, as well 
as for the development and implementation of health 
policy. Owing to the large decentralization of political 
power and a relatively high degree of local autonomy, 
we  can  consider  that  there  are  26  slightly  different 
healthcare systems in Switzerland, one for each can-
ton, acting autonomously in the organization of health-
care in their area. Since the new Health Insurance Law 
came into force in January 1996, universal access to 
health care has been achieved. Indeed, all Swiss resi-
dents have access to basic health insurance coverage 
that includes a comprehensive package of health ben-
efits identical for all insurees. According to the law, ser-
vices included should meet criteria for effectiveness, 
appropriateness and cost-effectiveness, and insurers 
are obliged to accept applicants, theoretically avoiding 
risk selection [34–36].
In Switzerland, interest towards chronic disease man-
agement (CDM) has been growing recently. CDM is in 
its infancy and programs have only been implemented 
lately.  No  plans  have  been  proposed  for  the  struc-
tured development of CDM at the national, cantonal 
or regional. Individual initiatives exist, however. The 
objectives of this exploratory survey were to search, 
list and extract data on existing chronic disease man-
agement programs in Switzerland.
Methods
Based  on  several  definitions  [13–18],  we  decided 
that programs would meet our operational definition 
of chronic disease management if their interventions 
specifically targeted adults (aged 18 years and over) 
with a chronic disease and included a multidisciplinary 
team (≥2 healthcare professionals). Programs need to 
last at least six months, to be structured, and to have 
been implemented and ‘active’ in December 2007. By 
structured intervention, we meant that activities were 
described, organized and planned. A structured inter-
vention goes beyond the usual activities of a single 
practitioner referring a diabetic patient to an endocri-
nologist or to a dietician, for example. The dimensions 
of  education  and  use  of  evidence-based  medicine 
have not been considered as mandatory as inclusion 
criteria, but their absence was considered a limitation 
of the program. Because the development of CDM is 
recent in Switzerland and we did not want to include 
comprehensive  programs  only,  we  purposively  used   
a rather loose operational definition of CDM.
To  find  chronic  disease  management  programs 
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Switzerland, we used various sources and a search 
strategy expected to be as comprehensive as possible,   
but certainly not exhaustive. First, we visited Swiss offi-
cial websites (i.e. Federal Office of Public Health, Swiss 
Health Observatory), and then Swiss-only web-pages 
using the generic internet engine Google with the fol-
lowing key words: ‘disease management’, ‘integrated 
care’, ‘case management’ and ‘managed care’. Then, 
we searched a medical electronic database (Medline 
OVID), and checked references from selected docu-
ments. Finally, we contacted key informants: person-
ally  known  individuals,  those  identified  as  possibly 
working  in  the  field  through  the  above-mentioned   
strategy,  individuals  responsible  for  managed  care 
and/or disease management programs in major Swiss 
health insurance companies and people recommended 
by previously contacted persons (snow ball strategy).
To facilitate the gathering of information pertaining to 
selected chronic disease management programs, we 
constructed an extraction grid that included the eight 
domains  proposed  by  Krumholz,  who  developed  a   
taxonomy  to  help  describe  and  compare  CDM  pro-
grams:  patient  population,  intervention  recipient, 
intervention  content,  delivery  personnel,  method  of 
communication, intensity and complexity, environment 
and clinical outcomes [37]. We also classified the com-
ponents of the intervention according to the following 
categories:  education/self-management,  multidiscipli-
narity (2 or more healthcare professionals described to 
be actively involved in patients’ care), measures and/
or feedback (process and/or patients’ outcome evalu-
ation,  with  complementary  feedback  mechanisms), 
planned contacts with patients, evidence-based medi-
cine/guidelines, teamwork (specific role for each health 
professionals (≥2) included in the program, structured 
roles organization), program evaluation, action plan. 
Data were collected during telephone and/or in-person 
interviews. When available, published documents were 
used to complement the information.
Results
Seven Swiss-based programs fulfilling our operational 
definition of CDM were identified. They are presented 
in an overview summary in Table 1 and briefly outlined 
below.
Programs  targeted  patients  with  diabetes,  hyper-
tension,  heart  failure,  obesity,  psychosis  and  breast   
cancer. Most identified programs were located in the 
French-speaking  region  of  Switzerland  and  imple-
mented between 2001 and 2007 by public hospitals or 
private healthcare support groups. The annual number   
of  ‘active’  patients  (i.e.  patients  benefiting  from  the 
program)  varied  between  65  and  250.  Most  often, 
the recipients of the interventions were patients, and   
the delivery personnel consisted of physicians, nurses, 
social  workers,  psychologists  and  case  managers 
with  various  backgrounds.  Patients  and  healthcare 
professionals  communicated  using  face-to-face  and 
telephone contacts, and the interventions were mainly 
in the ambulatory care sector. In decreasing order of 
frequency, the explicit components of the interventions 
were  education/self-management,  measures  and/or 
feedback, planned follow-up, use of evidence-based 
medicine/guidelines,  teamwork,  program  evaluations 
and action plan (Table 2).
The  largest  and  most  comprehensive  program   
‘Filière de soins Diabaide’ [39, 40], was created in 
2004 in Western Switzerland. The program, intended 
for  all  diabetic  patients  in  the  region,  is  based  on   
collaboration,  information  dissemination  and  care 
coordination among professionals. The components 
of the program are the «multidisciplinary cell», offering 
specialized ambulatory care (and access to a network 
of specialists such as diabetes specialists, dieticians, 
diabetes nurses, and foot specialists), patient edu-
cation, and telephone service and follow-up, as well 
as coordination of care, central data collection and 
a  website  with  up-to-date  information,  evidence-
based  guidelines,  and  patient  education  material. 
The program also developed an electronic medical 
record (aimed to be) accessible to all healthcare pro-
fessionals involved in the patient’s care. In 2006, an 
external evaluation was performed. It showed that 
the program had been successfully implemented and 
proved to be beneficial for the patients, in terms of 
reduction in mean HbA1c, total cholesterol concentra-
tions and blood pressure [40].
Discussion
The results of this exploratory survey show that, in a 
country  with  universal  health  insurance  coverage,  a 
majority of physicians working in solo practice and little 
incentive to develop new healthcare strategies, there 
are few chronic disease management programs fulfill-
ing our operational definition, and meeting the prere-
quisites of this concept. However, several others are 
under development. For example, a cantonal program 
for a coordinated action plan of indications and follow- 
up for alcohol dependent patients has officially started 
in  January  2008  in  Lausanne  [41],  and  Medgate,  a 
Swiss  telemedicine  support  service,  will  soon  pro-
pose CDM to heart failure and diabetic patients. Also, 
several networks of physicians are beginning to think 
about and/or develop CDM in various Swiss regions 
[42–44], and the ‘Taskforce Herzinsuffizienz’ has set 
up a theoretical program for heart failure patients [45]. 
All these initiatives may constitute good opportunities   This article is published in a peer reviewed section of the International Journal of Integrated Care   4
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for the further development of chronic disease man-
agement programs in Switzerland.
In Switzerland, continuing rises in healthcare expen-
ditures, the rise of the burden of chronic diseases due   
to population ageing and the increase in life-expec-
tancy, among others, as well as the reorganization of 
the healthcare system that includes recent discussions 
on CDM, may constitute a context prone to its develop-
ment. In addition, since many physicians will retire in 
the coming decades and a shortage of primary care 
physicians is likely to ensue [46], major adjustments 
will  need  to  appear  in  the  medical  workforce.  This 
may also favour the development of multidisciplinary 
approaches to care for chronic diseases.
Programs  and  models  of  CDM  should  be  adapted 
to the Swiss healthcare system, context and culture. 
However,  the  organized  development  of  CDM  pro-
grams  could  take  some  time  because  there  is  cur-
rently not much direct collaboration and care sharing 
between  physicians  and  nurses  or  other  healthcare 
professionals as well as between physicians from the 
hospital and the private ambulatory care sector, and 
also because each of the 26 Swiss cantons has its 
specific  healthcare  system.  In  addition,  appropriate 
support for the development and evaluation of CDM 
programs should be available (e.g. appropriate source 
of  evidence,  data  collection  of  clinical  and  process 
indicators), and regular group discussions and com-
parisons between leaders and partners of these types 
of programs should be organized to foster their qual-
ity. An additional favourable factor could be the recent 
interest of the Federal Office of Public Health (Dr. P. 
Indra, speech at PCS Suisse conference, Solothurn/
Switzerland, November 2007) and of the Public Health 
departments of the Swiss cantons.
Our results need to be interpreted in light of three limi-
tations. First, because the study was exploratory and 
our resources limited, the listing and description of 
existing CDM programs cannot be considered exhaus-
tive. More specifically, we do not know whether the 
larger number of programs found in the French-speak-
ing part of Switzerland reflects a real difference in the 
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Table 2. Explicit components of selected DM programs (decreasing 
order of frequency)
Component n
Education, self-management 7
Multidisiciplinarity (≥2/≥3 healthcare professionals) 7 (3/4)
Measures and/or feedback 7
Planned contacts with patients 5
Evidence-based medicine, guidelines 4
Teamwork 4
Program evaluations 1
Action plan 1
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For  the  future  development  of  CDM,  the  use  of  a   
common concept, appropriate evaluations of existing 
programs,  sharing  of  experiences  across  programs 
both at the national and international level, improve-
ment in data collection systems, the involvement and 
motivation of all healthcare stakeholders, proper reim-
bursement schemes as well as a strong political will 
and  leadership,  are  necessary.  Such  elements  may 
also be mandatory in other jurisdictions.
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development of CDM, or merely the lack of detection 
of existing programs in the German-speaking region. 
For example, the latter may be due to the persistent 
non-response of contacted persons despite multiple 
attempts, to the fact that multiple terms are used to 
designate CDM, or because investigators/physicians 
do not consider their programs as being CDM, which 
complicates  the  search.  Second,  there  is  no  stan-
dard definition of chronic disease management, and 
our operational definition was rather loose. This was 
done purposively, however, because we wanted to be 
as sensitive as possible in identifying CDM programs. 
We decided to include partial programs and describe 
their actual components, rather than exclude them. 
Finally, because our aim was to describe programs 
that were supposed to be implemented as long-term 
interventions in patients with chronic diseases, and 
more comprehensive than for example rehabilitation 
programs, we did not include programs that lasted <6 
months.
In  conclusion,  the  results  of  this  exploratory  survey 
showed  that  the  development  of  chronic  disease 
management  programs  is  currently  very  limited  in 
Switzerland. These results should lead to a more com-
prehensive and larger Swiss study aiming at examin-
ing how CDM could be tailored to the Swiss healthcare 
system  using  quantitative  and  qualitative  methods   
surveying  the  opinion  of  selected  stakeholders  in 
Switzerland  (patients,  physicians,  nurses,  insurers, 
politicians, administrators), and to identify barriers and 
facilitators to its broad-scale implementation.
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